resveratrol has been researched along with Invasiveness, Neoplasm in 69 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 19 (27.54) | 29.6817 |
| 2010's | 36 (52.17) | 24.3611 |
| 2020's | 14 (20.29) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, MD; Arteaga, CL; Brown, HA; Buck, JR; Cho, HP; Criswell, TL; Lindsley, CW; Scott, SA; Selvy, PE; Thomas, AL | 1 |
| Huang, P; Lu, X; Pan, Z; Song, F; Zhang, Q; Zhang, Y | 1 |
| Gu, J; Huang, X; Jiang, H; Ma, Q; Sha, H; Wang, G; Wang, P; Wang, Z; Xiao, Y | 1 |
| Madrid, A; Martín, SS; Párraga, M; Rojo, D; Silva Pinhal, MA; Valenzuela-Valderrama, M; Villena, J | 1 |
| Dong, FM; Li, MS; Liu, J; Zhu, XW | 1 |
| Cao, Q; Chen, FZ; Chen, HC; Khusbu, FY; Roy, M; Zhou, X | 1 |
| Büsselberg, D; Kubatka, P; Liskova, A; Mathews Samuel, S; Varghese, E | 1 |
| Hsieh, TC; Wu, JM | 1 |
| Aasbrenn, M; Abd El-Aty, AM; Abdu, A; Abraha, HB; Achour, A; Acquaroni, M; Addeo, P; Agback, P; Agback, T; Al-Alwan, M; Al-Mazrou, A; Al-Mohanna, F; Aliste, M; Almquist, J; Andel, J; Ando, M; Angelov, A; Annuar, MSM; Antwi, K; Arroliga, AC; Arruda, SLM; Asch, SM; Averous, G; Ayaz, S; Ayer, GB; Bachellier, P; Ball, S; Banijamali, AR; Barden, TC; Bartoncini, S; Bedanie, G; Bellò, M; Benić, F; Berhe, GG; Bertiger, G; Beumer, JH; Bhandari, B; Bond, DS; Boules, M; Braüner Christensen, J; Brown-Johnson, C; Burgstaller, S; Cao, L; Capasso, C; Carlevato, R; Carvalho, AE; Ceci, F; Chagas, ATA; Chavan, SG; Chen, AP; Chen, HC; Chen, J; Chen, Q; Chen, Y; Chen, YF; Christ, ER; Chu, CW; Covey, JM; Coyne, GO'; Cristea, MC; Currie, MG; Dahdal, DN; Dai, L; Dang, Z; de Abreu, NL; de Carvalho, KMB; de la Plaza Llamas, R; Deandreis, D; Del Prete, S; Dennis, JA; Deur, J; Díaz Candelas, DA; Divyapriya, G; Djanani, A; Dodig, D; Doki, Y; Doroshow, JH; Dos Santos, RC; Durairaj, N; Dutra, ES; Eguchi, H; Eisterer, W; Ekmann, A; Elakkad, A; Evans, WE; Fan, W; Fang, Z; Faria, HP; Farris, SG; Fenoll, J; Fernandez-Botran, R; Flores, P; Fujita, J; Gan, L; Gandara, DR; Gao, X; Garcia, AA; Garrido, I; Gebru, HA; Gerger, A; Germano, P; Ghamande, S; Ghebeh, H; Giver Jensen, T; Go, A; Goichot, B; Goldwater, M; Gontero, P; Greil, R; Gruenberger, B; Guarneri, A; Guo, Y; Gupta, S; Haxholdt Lunn, T; Hayek, AJ; He, ML; Hellín, P; Hepprich, M; Hernández de Rodas, E; Hill, A; Hndeya, AG; Holdsworth, LM; Hookey, L; Howie, W; Hu, G; Huang, JD; Huang, SY; Hubmann, E; Hwang, SY; Imamura, H; Imperiale, A; Jiang, JQ; Jimenez, JL; Jin, F; Jin, H; Johnson, KL; Joseph, A; Juwara, L; Kalapothakis, E; Karami, H; Karayağiz Muslu, G; Kawabata, R; Kerwin, J; Khan, I; Khin, S; Kidanemariam, HG; Kinders, RJ; Klepov, VV; Koehler, S; Korger, M; Kovačić, S; Koyappayil, A; Kroll, MH; Kuban, J; Kummar, S; Kung, HF; Kurokawa, Y; Laengle, F; Lan, J; Leal, HG; Lee, MH; Lemos, KGE; Li, B; Li, G; Li, H; Li, X; Li, Y; Li, Z; Liebl, W; Lillaz, B; Lin, F; Lin, L; Lin, MCM; Lin, Y; Lin, YP; Lipton, RB; Liu, J; Liu, W; Liu, Z; Lu, J; Lu, LY; Lu, YJ; Ludwig, S; Luo, Y; Ma, L; Ma, W; Machado-Coelho, GLL; Mahmoodi, B; Mahoney, M; Mahvash, A; Mansour, FA; Mao, X; Marinho, CC; Masferrer, JL; Matana Kaštelan, Z; Melendez-Araújo, MS; Méndez-Chacón, E; Miletić, D; Miller, B; Miller, E; Miller, SB; Mo, L; Moazzen, M; Mohammadniaei, M; Montaz-Rosset, MS; Mousavi Khaneghah, A; Mühlethaler, K; Mukhopadhyay, S; Mulugeta, A; Nambi, IM; Navarro, S; Nazmara, S; Neumann, HJ; Newman, EM; Nguyen, HTT; Nicolato, AJPG; Nicolotti, DG; Nieva, JJ; Nilvebrant, J; Nocentini, A; Nugent, K; Nunez-Rodriguez, DL; Nygren, PÅ; Oberli, A; Oderda, M; Odisio, B; Oehler, L; Otludil, B; Overman, M; Özdemir, M; Pace, KA; Palm, H; Parchment, RE; Parise, R; Passera, R; Pavlovic, J; Pecherstorfer, M; Peng, Z; Pérez Coll, C; Petzer, A; Philipp-Abbrederis, K; Pichler, P; Piekarz, RL; Pilati, E; Pimentel, JDSM; Posch, F; Prager, G; Pressel, E; Profy, AT; Qi, P; Qi, Y; Qiu, C; Rajasekhar, B; Ramia, JM; Raynor, HA; Reis, VW; Reubi, JC; Ricardi, U; Riedl, JM; Romano, F; Rong, X; Rubinstein, L; Rumboldt, Z; Sabir, S; Safaeinili, N; Sala, BM; Sandoval Castillo, L; Sau, M; Sbhatu, DB; Schulte, T; Scott, V; Shan, H; Shao, Y; Shariatifar, N; Shaw, JG; She, Y; Shen, B; Shernyukov, A; Sheth, RA; Shi, B; Shi, R; Shum, KT; Silva, JC; Singh, A; Sinha, N; Sirajudeen, AAO; Slaven, J; Sliwa, T; Somme, F; Song, S; Steinberg, SM; Subramaniam, R; Suetta, C; Sui, Y; Sun, B; Sun, C; Sun, H; Sun, Y; Supuran, CT; Surger, M; Svartz, G; Takahashi, T; Takeno, A; Tam, AL; Tang, Z; Tanner, JA; Tannich, E; Taye, MG; Tekle, HT; Thomas, GJ; Tian, Y; Tobin, JV; Todd Milne, G; Tong, X; Une, C; Vela, N; Venkateshwaran, U; Villagrán de Tercero, CI; Wakefield, JD; Wampfler, R; Wan, M; Wang, C; Wang, J; Wang, L; Wang, S; Waser, B; Watt, RM; Wei, B; Wei, L; Weldemichael, MY; Wellmann, IA; Wen, A; Wild, D; Wilthoner, K; Winder, T; Wing, RR; Winget, M; Wöll, E; Wong, KL; Wong, KT; Wu, D; Wu, Q; Wu, Y; Xiang, T; Xiang, Z; Xu, F; Xu, L; Yamasaki, M; Yamashita, K; Yan, H; Yan, Y; Yang, C; Yang, H; Yang, J; Yang, N; Yang, Y; Yau, P; Yu, M; Yuan, Q; Zhan, S; Zhang, B; Zhang, H; Zhang, J; Zhang, N; Zhang, Y; Zhao, X; Zheng, BJ; Zheng, H; Zheng, W; Zhou, H; Zhou, X; Zhu, S; Zimmer, DP; Zionts, D; Zitella, A; Zlott, J; Zolfaghari, K; Zuo, D; Zur Loye, HC; Žuža, I | 1 |
| Chen, Z; Fan, M; Feng, Y; Liang, B; Luo, G; Shi, J; Sun, Y; Wang, K; Xu, X; Yu, M; Zhuang, Q | 1 |
| Cho, KH; Jeong, BY; Kim, JY; Lee, HY; Park, CG | 1 |
| Fu, P; Jiang, N; Sang, M; Sun, X; Wang, X; Xie, L; Xu, H; Xu, Q; Zeng, L; Zhao, Q | 1 |
| Lari Najafi, M; Zhang, B | 1 |
| Alp, E; Kayhan, H; Onen, HI; Yar Saglam, AS | 1 |
| Chatterjee, S; Hembram, KC; Kundu, CN; Mandal, M; Pradhan, R; Sethy, C | 1 |
| Lu, YY; Su, SB; Sun, Y; Xie, XZ; Yang, MD; Zhou, QM; Zhou, WJ | 1 |
| Chen, K; Chen, M; Li, J; Li, X; Wang, G; Wei, G; Yan, Y; Zhou, C | 1 |
| Buhrmann, C; Goel, A; Shakibaei, M; Shayan, P | 1 |
| Liu, J; Tang, H; Ye, D; Zeng, X; Zhao, Y | 1 |
| Kim, DH; Suh, J; Surh, YJ | 1 |
| Wang, L; Yan, L; Yang, T; Zhang, J; Zhou, J; Zhu, M | 1 |
| Hasegawa, K; Inagaki, Y; Rong, L; Sakamoto, Y; Sawakami, T; Song, P; Tang, W; Xia, J | 1 |
| Geng, W; Guo, X; Ji, H; Liu, Z; Ma, Y; Wang, L; Xiong, Y; Zhang, L | 1 |
| Cho, KH; Jeong, BY; Lee, HY; Park, CG | 1 |
| Chang, MC; Chang, YC; Chen, CC; Chen, KY | 1 |
| Beetch, M; Flanagan, JM; Flower, K; Harandi-Zadeh, S; Lubecka, K; Shen, K; Stefanska, B; Suderman, M | 1 |
| Chen, TY; Chiou, HL; Hsieh, MJ; Lin, CW; Lin, PY; Yang, SF; Yeh, CB | 1 |
| Chen, WJ; Hong, HM; Hsu, LS; Lin, CL; Pan, MH; Tsai, JH; Way, TD | 1 |
| Chung, MY; Jang, TS; Kang, NJ; Lee, HJ; Lee, KW; Seo, SG; Song, NR | 1 |
| Cai, J; Fu, X; Ji, Q; Li, Q; Liu, X; Qin, J; Ren, J; Sui, H; Sun, J; Zhang, L; Zhou, L | 1 |
| Bin, Z; Pei-jun, W; Shan, Z; Xiang, W; Yang, G | 1 |
| Andreoli, SC; de Andrade, RV; de Carvalho, GP; Garicochea, B; Gasparini, NJ; Pogue, RE | 1 |
| Choi, YJ; Jeong, MH; Jeong, SK; Jo, WS; Lee, CW; Lee, KY; Oh, SJ; Park, YS; Yang, K | 1 |
| Chen, CT; Chen, MK; Chou, MY; Chuang, YT; Hsieh, YH; Lin, CW; Lin, FY; Tang, CH; Yang, SF | 1 |
| Chien, MH; Hsiao, M; Hsieh, FK; Lee, WJ; Tan, P; Tang, CH; Yang, SF | 1 |
| Cai, J; Han, Z; Ji, Q; Jiang, H; Li, Q; Liu, X; Ren, J; Sui, H; Yan, L; Zhou, L | 1 |
| Cao, Y; Guo, A; Jiao, Y; Li, H; Li, Y; Liu, Y; Qu, X; Wang, S; Xu, X; Zhao, J | 1 |
| Cho, KH; Hur, GM; Jeong, BY; Kim, SH; Kim, YN; Lee, HY; Park, CG | 1 |
| Cao, L; Chen, X; Lei, J; Li, W; Ma, Q | 1 |
| Bianchi, L; Cao, Y; Corana, F; Ferraro, D; Jensen, LD; Maccario, C; Mannucci, B; Savio, M; Stivala, LA; Vaccarone, R | 1 |
| Buhrmann, C; Goel, A; Popper, B; Shakibaei, M; Shayan, P | 1 |
| Chae, SY; Lee, KJ; Park, G; Park, JO; Park, SY | 1 |
| Cao, L; Chen, X; Li, W; Ma, Q; Xiao, X | 1 |
| Choi, KC; Hwang, KA; Kim, CW | 1 |
| Amini, R; Heydari, K; Karimi Dermani, F; Mahdavinezhad, A; Najafi, R; Saidijam, M | 1 |
| Bai, Y; Hu, L; Lei, Y; Li, R; Mao, Q; Qin, Y; Wang, Q; Yang, H; Yang, Y; Zhang, G | 1 |
| Cho, DY; Cho, KH; Choe, SR; Kang, J; Kim, YN; Lee, HY; Park, CG | 1 |
| Kundu, JK; Surh, YJ | 1 |
| Fang, Y; Liang, X; Liu, J; Qin, X; Wu, H; Zhang, Y | 1 |
| Chen, J; Chen, MH; Mao, W; Peng, TL; Song, X | 1 |
| Ho, CT; Huang, HW; Weng, CJ; Wu, CF; Wu, CH; Yen, GC | 1 |
| Charles, AL; Chen, WC; Chen, YH; Chen, YL; Chong, IW; Chou, SH; Hung, CY; Hwang, JJ; Lin, FY; Liu, PL; Ping, YH; Tsai, JR | 1 |
| Cho, GJ; Choi, J; Choi, WS; Jeong, JY; Kang, S; Kang, SS; Kim, HJ; Kim, N; Ku, BM; Lee, DH; Lee, YK; Roh, GS; Ryu, J; Yang, Y | 1 |
| Chen, H; Chen, X; Liu, G; Tang, L; Wang, H; Wu, C; Yang, Y; Zhang, H; Zhao, M | 1 |
| Jajoo, S; Kaur, T; Mukherjea, D; Ramkumar, V; Rybak, LP; Sheehan, K; Sheth, S | 1 |
| Miura, D; Miura, Y; Yagasaki, K | 1 |
| Bracke, M; Bruyneel, E; Garel, MC; Gespach, C; Navarro, N; Porteu, F; Rodrigue, CM; Romeo, PH | 1 |
| Stein, JM; Ulrich, S; Wolter, F | 1 |
| Alston-Mills, B; Bottone, FG; Eling, TE; Ishibashi, M; Kim, JS; Moon, Y | 1 |
| Brown, J; Le, AD; Lu, QY; Tang, X; Zhang, Q; Zhang, ZF | 1 |
| He, W; Hu, Y; Liu, X; Sun, C; Wang, Y; Wei, W; Wu, T | 1 |
| Guo, T; He, WJ; Hu, Y; Sun, CY; Tan, H; Wang, HF; Zhang, XP | 1 |
| Azios, NG; Cammer, M; Cubano, LA; Dharmawardhane, SF; Harris, M; Krishnamoorthy, L | 1 |
| He, TP; Li, K; Liang, NC; Mo, LE; Qin, YM | 1 |
| Chiang, EP; Sun, YC; Tang, FY | 1 |
| Chen, KS; Chen, NC; Hsieh, HS; Su, YC; Tang, FY | 1 |
| Aiello, FB; Brunetti, M; Caltagirone, S; Natali, PG; Piantelli, M; Poggi, A; Ranelletti, FO; Rossi, C | 1 |
| Kozuki, Y; Miura, Y; Yagasaki, K | 1 |
| Bedin, C; Bioulac-Sage, P; De Lédinghen, V; Desmoulière, A; Krisa, S; Monvoisin, A; Neaud, V; Payrastre, B; Rosenbaum, J | 1 |
5 review(s) available for resveratrol and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Chalcones; Curcumin; Disease Progression; Endothelial Cells; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; MicroRNAs; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Oxygen; Phytochemicals; Phytotherapy; Prognosis; Reactive Oxygen Species; Resveratrol; Signal Transduction | 2020 |
Use of microRNAs in directing therapy and evaluating treatment response in colorectal cancer.
Topics: Antineoplastic Agents; Capecitabine; Chemoradiotherapy, Adjuvant; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Gene Expression Regulation, Neoplastic; Genetic Markers; Humans; MicroRNAs; Neoplasm Invasiveness; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Resveratrol; Stilbenes | 2014 |
Anti-metastatic potential of resveratrol and its metabolites by the inhibition of epithelial-mesenchymal transition, migration, and invasion of malignant cancer cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Movement; Epithelial-Mesenchymal Transition; Fruit; Humans; Neoplasm Invasiveness; Neoplasms; Phytotherapy; Plant Extracts; Resveratrol; Stilbenes | 2016 |
Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Apoptosis; Carcinogens; Cell Survival; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B; Protein Kinase C; Resveratrol; Signal Transduction; Stilbenes | 2008 |
Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Cell Cycle; Cell Division; Humans; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neoplasms, Experimental; Neovascularization, Pathologic; Resveratrol; Signal Transduction; Stilbenes; Tumor Cells, Cultured | 2005 |
2 trial(s) available for resveratrol and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Topics: 3-Hydroxybutyric Acid; Acetazolamide; Acrylates; Administration, Intravenous; Adolescent; Adult; Aerosols; Afghanistan; Aflatoxin M1; Agaricales; Aged; Aged, 80 and over; Agricultural Irrigation; Air Pollutants; alpha-L-Fucosidase; Amino Acid Sequence; Androgen Antagonists; Animals; Antibodies, Bacterial; Antigens, Bacterial; Antineoplastic Agents; Antioxidants; Apoptosis; Artifacts; Autophagy; B7-H1 Antigen; Bacterial Proteins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Bile; Bioelectric Energy Sources; Biosensing Techniques; Body Mass Index; Brain; Brazil; Breast Neoplasms; Bufo arenarum; Burkholderia; C-Reactive Protein; Cadmium; Carbon Compounds, Inorganic; Carbon-13 Magnetic Resonance Spectroscopy; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Carcinoma, Transitional Cell; Case-Control Studies; CD4-Positive T-Lymphocytes; Cell Count; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Characiformes; Child; China; Cities; Cobalt; Colonic Neoplasms; Copper Sulfate; Cross-Sectional Studies; Cyclin-Dependent Kinase Inhibitor p16; Cytokines; Deoxycytidine; Diagnosis, Differential; Digestive System; Dihydroxyphenylalanine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA Barcoding, Taxonomic; DNA, Bacterial; Dose-Response Relationship, Drug; Down-Regulation; Edetic Acid; Electrochemical Techniques; Electrodes; Embolization, Therapeutic; Embryo, Nonmammalian; Environmental Monitoring; Enzyme-Linked Immunosorbent Assay; Epithelial-Mesenchymal Transition; Fatty Acids; Feces; Female; Follow-Up Studies; Food Contamination; Forkhead Box Protein M1; Fresh Water; Fungicides, Industrial; Gallium Isotopes; Gallium Radioisotopes; Gastrectomy; Gastric Bypass; Gastric Outlet Obstruction; Gastroplasty; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Bacterial; Genetic Markers; Genome, Bacterial; Genome, Mitochondrial; Glioma; Glycogen Synthase Kinase 3 beta; Goats; Gonads; Guatemala; Halomonadaceae; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hepacivirus; Histone-Lysine N-Methyltransferase; Hormones; Humans; Hydroxybutyrate Dehydrogenase; Hypersplenism; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Iran; Japan; Lactuca; Laparoscopy; Larva; Ligands; Liver Neoplasms; Lymphocyte Activation; Macrophages; Malaria; Male; Mercury; Metabolic Syndrome; Metals, Heavy; Mice; Middle Aged; Milk, Human; Mitochondria; Models, Molecular; Molecular Structure; Mothers; Multilocus Sequence Typing; Muscles; Mutation; Nanocomposites; Nanotubes, Carbon; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Cells, Circulating; Neoplastic Stem Cells; Neuroimaging; Nitriles; Nitrogen Isotopes; Non-alcoholic Fatty Liver Disease; Nuclear Magnetic Resonance, Biomolecular; Obesity; Obesity, Morbid; Oligopeptides; Oxidation-Reduction; Pancreatic Neoplasms; Particle Size; Particulate Matter; Pepsinogen A; Pesticides; Pharmacogenetics; Phosphatidylinositol 3-Kinases; Phospholipids; Phylogeny; Plasmodium ovale; Plasmodium vivax; Platelet Count; Polyhydroxyalkanoates; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postoperative Complications; Pregnancy; Prevalence; Prognosis; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Domains; Proto-Oncogene Proteins c-akt; Proton Magnetic Resonance Spectroscopy; Pseudogenes; PTEN Phosphohydrolase; Pyrazoles; Pyrimidines; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Rats, Long-Evans; Rats, Sprague-Dawley; RAW 264.7 Cells; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptor, Notch3; Receptors, G-Protein-Coupled; Receptors, Urokinase Plasminogen Activator; Recombinant Proteins; Repressor Proteins; Resveratrol; Retrospective Studies; Risk Assessment; Risk Factors; RNA, Messenger; RNA, Ribosomal, 16S; Salinity; Salvage Therapy; Seasons; Sequence Analysis, DNA; Seroepidemiologic Studies; Signal Transduction; Skin; Snails; Soluble Guanylyl Cyclase; Solutions; Spain; Species Specificity; Spheroids, Cellular; Splenic Artery; Stomach Neoplasms; Streptococcus pneumoniae; Structure-Activity Relationship; Sulfonamides; Sunlight; Surface Properties; Surgical Instruments; Surgical Wound Infection; Survival Rate; Tetrahydrouridine; Thinness; Thrombocytopenia; Tissue Distribution; Titanium; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Turkey; Ubiquinone; Urologic Neoplasms; Viral Envelope Proteins; Wastewater; Water Pollutants, Chemical; Weather; Wnt Signaling Pathway; Xenograft Model Antitumor Assays; Young Adult | 2007 |
Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/β-catenin signal pathway.
Topics: Aged; Antineoplastic Agents, Phytogenic; beta Catenin; Cell Line, Tumor; Cell Nucleus; Colorectal Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Matrix Metalloproteinase 7; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Proto-Oncogene Proteins c-myc; Resveratrol; RNA, Long Noncoding; RNA, Neoplasm; Stilbenes; Wnt Signaling Pathway | 2013 |
62 other study(ies) available for resveratrol and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness.
Topics: Breast Neoplasms; Drug Design; Enzyme Inhibitors; Humans; Isoenzymes; Neoplasm Invasiveness; Phospholipase D | 2009 |
Resveratrol inhibits the migration, invasion and epithelial-mesenchymal transition in liver cancer cells through up- miR-186-5p expression.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; MicroRNAs; Neoplasm Invasiveness; Resveratrol | 2021 |
Resveratrol inhibits the expression of RYR2 and is a potential treatment for pancreatic cancer.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Knockdown Techniques; Humans; Neoplasm Invasiveness; Pancreatic Neoplasms; PTEN Phosphohydrolase; Resveratrol; Ryanodine Receptor Calcium Release Channel | 2022 |
Resveratrol Decreases the Invasion Potential of Gastric Cancer Cells.
Topics: Cell Line, Tumor; Humans; Neoplasm Invasiveness; NF-kappa B; Resveratrol; Stomach Neoplasms; Superoxide Dismutase | 2022 |
Resveratrol Nanoparticles Suppresses Migration and Invasion of Renal Cell Carcinoma Cells by Inhibiting Matrix Metalloproteinase 2 Expression and Extracellular Signal-Regulated Kinase Pathway.
Topics: Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Extracellular Signal-Regulated MAP Kinases; Humans; Kidney Neoplasms; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Nanoparticles; Neoplasm Invasiveness; Resveratrol | 2022 |
Resveratrol induces depletion of TRAF6 and suppresses prostate cancer cell proliferation and migration.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Neoplasm Invasiveness; NF-kappa B; Prostatic Neoplasms; Resveratrol; Snail Family Transcription Factors; Xenograft Model Antitumor Assays | 2020 |
Resveratrol Suppresses Prostate Cancer Epithelial Cell Scatter/Invasion by Targeting Inhibition of Hepatocyte Growth Factor (HGF) Secretion by Prostate Stromal Cells and Upregulation of E-cadherin by Prostate Cancer Epithelial Cells.
Topics: Antigens, CD; Cadherins; Cell Line, Tumor; Cell Movement; Culture Media, Conditioned; Epithelial Cells; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Humans; Male; Neoplasm Invasiveness; Phenotype; Prostate; Prostatic Neoplasms; Resveratrol; Signal Transduction; Stromal Cells; Transcriptional Activation | 2020 |
Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells.
Topics: 5-Methylcytosine; Cell Line, Tumor; Cell Movement; DNA Methylation; HEK293 Cells; Humans; Male; Mixed Function Oxygenases; Neoplasm Invasiveness; PC-3 Cells; Prostatic Neoplasms; Proto-Oncogene Proteins; Resveratrol; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinase-3; Up-Regulation | 2020 |
Zeb1 for RCP-induced oral cancer cell invasion and its suppression by resveratrol.
Topics: Adaptor Proteins, Signal Transducing; Cell Line, Tumor; Epithelial-Mesenchymal Transition; ErbB Receptors; Head and Neck Neoplasms; Humans; Integrin beta1; Matrix Metalloproteinase 14; Membrane Proteins; Models, Biological; Neoplasm Invasiveness; Resveratrol; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Transcription Factor 4; Zinc Finger E-box-Binding Homeobox 1 | 2020 |
Resveratrol suppresses the growth and metastatic potential of cervical cancer by inhibiting STAT3
Topics: Animals; Antineoplastic Agents; Cell Movement; Cell Proliferation; Female; HeLa Cells; Humans; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Phosphorylation; Resveratrol; STAT3 Transcription Factor; Tumor Burden; Tyrosine; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2020 |
Resveratrol inhibits skin squamous cell carcinoma proliferation, migration and invasion through up-regulating miR-126.
Topics: Apoptosis; beta Catenin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Neoplasm Invasiveness; Resveratrol; Skin Neoplasms; Transcriptional Activation; Up-Regulation; Wnt Signaling Pathway | 2020 |
Resveratrol enhances the sensitivity of FL118 in triple-negative breast cancer cell lines via suppressing epithelial to mesenchymal transition.
Topics: Apoptosis; Benzodioxoles; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Synergism; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Indolizines; Neoplasm Invasiveness; Neoplasm Proteins; Resveratrol; Triple Negative Breast Neoplasms | 2021 |
Nano formulated Resveratrol inhibits metastasis and angiogenesis by reducing inflammatory cytokines in oral cancer cells by targeting tumor associated macrophages.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Cell Line, Tumor; Chick Embryo; Cytokines; Female; Humans; Inflammation; Mice, Inbred BALB C; Mouth Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Resveratrol; THP-1 Cells; Tumor-Associated Macrophages | 2021 |
Resveratrol Enhances Inhibition Effects of Cisplatin on Cell Migration and Invasion and Tumor Growth in Breast Cancer MDA-MB-231 Cell Models In Vivo and In Vitro.
Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cisplatin; Drug Synergism; Epithelial-Mesenchymal Transition; Female; Humans; Mice, Inbred BALB C; Neoplasm Invasiveness; Phosphorylation; Resveratrol; Signal Transduction; Transforming Growth Factor beta1; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2021 |
Resveratrol inhibits hepatocellular carcinoma progression driven by hepatic stellate cells by targeting Gli-1.
Topics: Carcinoma, Hepatocellular; Disease Progression; Hep G2 Cells; Hepatic Stellate Cells; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-6; Liver Neoplasms; Neoplasm Invasiveness; Neovascularization, Pathologic; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Resveratrol; Stilbenes; Vascular Endothelial Growth Factor A; Zinc Finger Protein GLI1 | 2017 |
Resveratrol Regulates Colorectal Cancer Cell Invasion by Modulation of Focal Adhesion Molecules.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Adhesion Molecules; Cell Movement; Colorectal Neoplasms; Dose-Response Relationship, Drug; Focal Adhesion Kinase 1; Focal Adhesions; HCT116 Cells; Humans; Integrin beta1; Neoplasm Invasiveness; NF-kappa B; Protein Kinase Inhibitors; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes; Time Factors; Tumor Microenvironment | 2017 |
Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal cell carcinoma cells.
Topics: Cadherins; Carcinoma, Renal Cell; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes; Vimentin | 2018 |
Resveratrol suppresses migration, invasion and stemness of human breast cancer cells by interfering with tumor-stromal cross-talk.
Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Movement; Cell Proliferation; Enzyme Activation; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Neoplasm Invasiveness; Neoplastic Stem Cells; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; SOXB1 Transcription Factors; STAT3 Transcription Factor | 2018 |
Resveratrol inhibits Interleukin-6 induced invasion of human gastric cancer cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Neoplastic; Humans; Interleukin-6; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Invasiveness; Resveratrol; Signal Transduction; Stilbenes; Stomach Neoplasms; Up-Regulation | 2018 |
Shufeng Jiedu Capsule and its active ingredients induce apoptosis, inhibit migration and invasion, and enhances doxorubicin therapeutic efficacy in hepatocellular carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Doxorubicin; Drugs, Chinese Herbal; Hep G2 Cells; Humans; Liver Neoplasms; Neoplasm Invasiveness; Quercetin; Real-Time Polymerase Chain Reaction; Resveratrol; Signal Transduction; Stilbenes | 2018 |
Resveratrol inhibits proliferation, migration and invasion of multiple myeloma cells via NEAT1-mediated Wnt/β-catenin signaling pathway.
Topics: Aged; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Matrix Metalloproteinase 7; Middle Aged; Multiple Myeloma; Neoplasm Invasiveness; Resveratrol; RNA, Long Noncoding; Survivin; Unfolded Protein Response; Wnt Signaling Pathway | 2018 |
The YB-1/EZH2/amphiregulin signaling axis mediates LPA-induced breast cancer cell invasion.
Topics: Amphiregulin; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Movement; Cell Proliferation; Drug Screening Assays, Antitumor; Enhancer of Zeste Homolog 2 Protein; Epithelial-Mesenchymal Transition; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Lysophospholipids; MCF-7 Cells; Neoplasm Invasiveness; Phosphorylation; Resveratrol; RNA, Small Interfering; Signal Transduction; Y-Box-Binding Protein 1 | 2019 |
Resveratrol induced premature senescence and inhibited epithelial-mesenchymal transition of cancer cells via induction of tumor suppressor Rad9.
Topics: A549 Cells; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; MCF-7 Cells; Neoplasm Invasiveness; Reactive Oxygen Species; Resveratrol; RNA, Small Interfering; Snail Family Transcription Factors; Tumor Suppressor Protein p53; Up-Regulation; Wound Healing | 2019 |
Stilbenoid-Mediated Epigenetic Activation of Semaphorin 3A in Breast Cancer Cells Involves Changes in Dynamic Interactions of DNA with DNMT3A and NF1C Transcription Factor.
Topics: Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; DNA; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; Epigenesis, Genetic; Female; Gene Expression; Gene Knockdown Techniques; Gene Silencing; Homeodomain Proteins; Humans; Neoplasm Invasiveness; NFI Transcription Factors; Promoter Regions, Genetic; Resveratrol; Semaphorin-3A; Stilbenes; Transcription Factors | 2019 |
The antimetastatic effects of resveratrol on hepatocellular carcinoma through the downregulation of a metastasis-associated protease by SP-1 modulation.
Topics: Anticarcinogenic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Neoplasm Invasiveness; Phosphorylation; Resveratrol; Signal Transduction; Sp1 Transcription Factor; Stilbenes; Urokinase-Type Plasminogen Activator | 2013 |
3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Topics: Anticarcinogenic Agents; beta Catenin; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Humans; MCF-7 Cells; Neoplasm Invasiveness; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Resveratrol; Stilbenes; Wnt Signaling Pathway | 2013 |
Quercetin suppresses invasion and migration of H-Ras-transformed MCF10A human epithelial cells by inhibiting phosphatidylinositol 3-kinase.
Topics: Breast Neoplasms; Cell Line, Transformed; Cell Movement; Down-Regulation; Enzyme Inhibitors; Epithelial Cells; Genes, ras; Humans; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins p21(ras); Quercetin; Resveratrol; Signal Transduction; Stilbenes; Wine | 2014 |
Effects of resveratrol on oral squamous cell carcinoma (OSCC) cells in vitro.
Topics: Anticarcinogenic Agents; Carcinoma, Squamous Cell; Cell Adhesion; Cell Line, Tumor; Cell Movement; Colorimetry; Humans; Mouth Neoplasms; Neoplasm Invasiveness; Resveratrol; Stilbenes | 2014 |
Interferon gamma induced by resveratrol analog, HS-1793, reverses the properties of tumor associated macrophages.
Topics: Animals; Cell Line, Tumor; Cell Movement; Female; Interferon-gamma; Macrophages; Mice; Mice, Inbred C3H; Naphthols; Neoplasm Invasiveness; Neoplasms; Resorcinols; Resveratrol; Stilbenes | 2014 |
Resveratrol suppresses TPA-induced matrix metalloproteinase-9 expression through the inhibition of MAPK pathways in oral cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Survival; Down-Regulation; Enzyme Activation; Head and Neck Neoplasms; Humans; JNK Mitogen-Activated Protein Kinases; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mouth Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Resveratrol; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Stilbenes; Tetradecanoylphorbol Acetate; Tongue Neoplasms | 2015 |
Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas.
Topics: 3' Untranslated Regions; Adult; Animals; Antineoplastic Agents; Binding Sites; Bone Neoplasms; Cell Line, Tumor; Cell Movement; CREB-Binding Protein; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; Male; Matrix Metalloproteinase 2; Mice, SCID; MicroRNAs; Neoplasm Invasiveness; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Resveratrol; Signal Transduction; Stilbenes; Time Factors; Transcription, Genetic; Transfection; Xenograft Model Antitumor Assays; Young Adult | 2015 |
Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cadherins; Cell Line, Tumor; Cell Movement; Colorectal Neoplasms; Disease Models, Animal; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Invasiveness; Promoter Regions, Genetic; Protein Binding; Resveratrol; Signal Transduction; Smad Proteins; Snail Family Transcription Factors; Stilbenes; Transcription Factors; Transcription, Genetic; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays | 2015 |
Resveratrol Inhibits the Invasion of Glioblastoma-Initiating Cells via Down-Regulation of the PI3K/Akt/NF-κB Signaling Pathway.
Topics: Animals; Cell Adhesion; Cell Line, Tumor; Cell Survival; Dacarbazine; Down-Regulation; Glioblastoma; Humans; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Invasiveness; Neoplasm Transplantation; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes; Temozolomide | 2015 |
Resveratrol attenuates norepinephrine-induced ovarian cancer invasiveness through downregulating hTERT expression.
Topics: Adrenergic beta-Antagonists; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Neoplasm Invasiveness; Norepinephrine; Ovarian Neoplasms; Phosphorylation; Resveratrol; Signal Transduction; Snail Family Transcription Factors; src-Family Kinases; Stilbenes; Telomerase; Transfection | 2016 |
Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway.
Topics: Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Pancreatic Neoplasms; Reactive Oxygen Species; Resveratrol; Signal Transduction; Stilbenes; Urokinase-Type Plasminogen Activator | 2016 |
Resveratrol analogue 4,4'-dihydroxy-trans-stilbene potently inhibits cancer invasion and metastasis.
Topics: Animals; Apoptosis; Human Umbilical Vein Endothelial Cells; Humans; Lung Neoplasms; Male; Mice; Neoplasm Invasiveness; Neoplasms, Experimental; Resveratrol; Stilbenes; Xenograft Model Antitumor Assays | 2016 |
Sirt1 Is Required for Resveratrol-Mediated Chemopreventive Effects in Colorectal Cancer Cells.
Topics: Acetylation; Antineoplastic Agents; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Dose-Response Relationship, Drug; HCT116 Cells; Humans; Ki-67 Antigen; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Oligonucleotides, Antisense; Phosphorylation; Receptors, CXCR4; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes; Time Factors; Transcription Factor RelA; Transfection | 2016 |
Gold-conjugated resveratrol nanoparticles attenuate the invasion and MMP-9 and COX-2 expression in breast cancer cells.
Topics: Cell Movement; Cyclooxygenase 2; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Gold; Heme Oxygenase-1; Humans; Matrix Metalloproteinase 9; MCF-7 Cells; Nanoconjugates; Neoplasm Invasiveness; Proto-Oncogene Proteins c-akt; Resveratrol; Stilbenes | 2016 |
Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathways.
Topics: Acetylcysteine; Cell Line, Tumor; Cell Movement; Diabetes Complications; Flavonoids; Free Radical Scavengers; Gene Expression Regulation, Neoplastic; Glucose; Humans; Hyperglycemia; Imidazoles; MAP Kinase Signaling System; Neoplasm Invasiveness; p38 Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; Pyridines; Reactive Oxygen Species; Resveratrol; Stilbenes | 2016 |
Resveratrol Inhibits Proliferation, Invasion, and Epithelial-Mesenchymal Transition by Increasing miR-200c Expression in HCT-116 Colorectal Cancer Cells.
Topics: Cell Movement; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; MicroRNAs; Neoplasm Invasiveness; Resveratrol; Stilbenes; Up-Regulation | 2017 |
Inhibitory effects of resveratrol on the adhesion, migration and invasion of human bladder cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; JNK Mitogen-Activated Protein Kinases; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Phosphorylation; Resveratrol; Stilbenes; Urinary Bladder; Urinary Bladder Neoplasms | 2017 |
Resveratrol suppresses breast cancer cell invasion by inactivating a RhoA/YAP signaling axis.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Female; Humans; Neoplasm Invasiveness; Phosphoproteins; Resveratrol; rhoA GTP-Binding Protein; Signal Transduction; Stilbenes; Transcription Factors; YAP-Signaling Proteins | 2017 |
Resveratrol inhibits hypoxia-induced metastasis potential enhancement by restricting hypoxia-induced factor-1 alpha expression in colon carcinoma cells.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Cell Adhesion; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cell Survival; Colonic Neoplasms; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Metastasis; Resveratrol; RNA, Messenger; Stilbenes; Vascular Endothelial Growth Factor A | 2008 |
Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9.
Topics: Blotting, Western; Cell Line, Tumor; Cell Movement; Cytochrome P-450 CYP1A1; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Polychlorinated Dibenzodioxins; Proto-Oncogene Proteins c-jun; Receptors, Aryl Hydrocarbon; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Signal Transduction; Stilbenes; Stomach Neoplasms; Transfection | 2009 |
Evaluation of anti-invasion effect of resveratrol and related methoxy analogues on human hepatocarcinoma cells.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Liver Neoplasms; Neoplasm Invasiveness; Resveratrol; Stilbenes | 2010 |
Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Survival; Down-Regulation; Gene Silencing; Heme Oxygenase-1; Humans; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Neoplasm Invasiveness; NF-kappa B; Osmolar Concentration; Resveratrol; RNA, Small Interfering; Signal Transduction; Stilbenes | 2010 |
Resveratrol reduces TNF-α-induced U373MG human glioma cell invasion through regulating NF-κB activation and uPA/uPAR expression.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Collagen; Drug Combinations; Gene Expression Regulation, Neoplastic; Glioma; Humans; Laminin; Neoplasm Invasiveness; NF-kappa B; Proteoglycans; Receptors, Urokinase Plasminogen Activator; Resveratrol; RNA, Messenger; Stilbenes; Tumor Necrosis Factor-alpha; Urokinase-Type Plasminogen Activator | 2011 |
Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Topics: Antineoplastic Agents, Phytogenic; Cadherins; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Fibronectins; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Resveratrol; Stilbenes; Transforming Growth Factor beta1; Vimentin | 2013 |
Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromones; Enzyme Inhibitors; Estrogens; Flow Cytometry; Genes, Tumor Suppressor; Humans; Male; Mice; Mice, SCID; MicroRNAs; Morpholines; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Oligonucleotides; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Resveratrol; RNA, Small Interfering; Stilbenes; Wound Healing | 2012 |
Resveratrol inhibits hepatoma cell invasion by suppressing gene expression of hepatocyte growth factor via its reactive oxygen species-scavenging property.
Topics: Animals; Carcinoma, Hepatocellular; Free Radical Scavengers; Gene Expression; Hepatocyte Growth Factor; Hypoxanthine; Liver Neoplasms; Male; Neoplasm Invasiveness; Rats; Reactive Oxygen Species; Resveratrol; Stilbenes; Tumor Cells, Cultured; Xanthine Oxidase | 2004 |
The cancer chemopreventive agent resveratrol induces tensin, a cell-matrix adhesion protein with signaling and antitumor activities.
Topics: Actins; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Cell Adhesion; Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Cycloheximide; Cytoplasm; Cytoskeleton; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; K562 Cells; Microfilament Proteins; Neoplasm Invasiveness; Neoplasms; Phosphatidylinositol 3-Kinases; Protein Synthesis Inhibitors; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Stilbenes; Tensins; Time Factors | 2005 |
The anti-invasive activity of cyclooxygenase inhibitors is regulated by the transcription factor ATF3 (activating transcription factor 3).
Topics: Activating Transcription Factor 3; Allyl Compounds; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Chromans; Colorectal Neoplasms; Cyclooxygenase Inhibitors; Disulfides; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Male; Mice; Mice, Nude; Microarray Analysis; Neoplasm Invasiveness; Resveratrol; RNA, Messenger; Stilbenes; Sulindac; Thiazolidinediones; Transcription Factors; Transplantation, Heterologous; Troglitazone; Up-Regulation | 2005 |
Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Resveratrol; RNA, Messenger; Stilbenes; Tongue Neoplasms; Transcriptional Activation; Vascular Endothelial Growth Factors | 2005 |
Resveratrol downregulates the constitutional activation of nuclear factor-kappaB in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle, and induction of apoptosis.
Topics: Apoptosis; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Nucleus; DNA Replication; Humans; Multiple Myeloma; Neoplasm Invasiveness; NF-kappa B; Resveratrol; Stilbenes | 2006 |
Resveratrol as a novel agent for treatment of multiple myeloma with matrix metalloproteinase inhibitory activity.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Multiple Myeloma; Neoplasm Invasiveness; Plants, Medicinal; Polygonum; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes; X-Linked Inhibitor of Apoptosis Protein | 2006 |
Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells.
Topics: Actins; Adenocarcinoma; Breast Neoplasms; cdc42 GTP-Binding Protein; Cell Line, Tumor; Cell Movement; Cytoskeleton; Dose-Response Relationship, Drug; Epidermal Growth Factor; Estradiol; Estrogens; Female; Genes, Dominant; Humans; Neoplasm Invasiveness; Neoplasms, Hormone-Dependent; Pseudopodia; rac GTP-Binding Proteins; Recombinant Fusion Proteins; Resveratrol; Stilbenes; Transfection | 2007 |
[Study on the effect of resveratrol on metastasis-associated ability of ovarian carcinoma HO-8910PM cells in vitro].
Topics: Antineoplastic Agents, Phytogenic; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drugs, Chinese Herbal; Female; Flow Cytometry; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Ovarian Neoplasms; Plants, Medicinal; Resveratrol; Stilbenes | 2007 |
Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Enzyme Activation; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neuregulin-1; Phosphorylation; Receptor, ErbB-2; Resveratrol; Stilbenes; Tissue Inhibitor of Metalloproteinases | 2008 |
Resveratrol inhibits migration and invasion of human breast-cancer cells.
Topics: Anticarcinogenic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Enzyme Activation; Gene Expression; Humans; Insulin-Like Growth Factor I; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; Stilbenes | 2008 |
Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential.
Topics: Animals; Anticarcinogenic Agents; Apigenin; Catechin; Cell Division; Curcumin; Female; Flavonoids; Growth Inhibitors; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasm Transplantation; Quercetin; Resveratrol; Stilbenes; Tamoxifen; Tumor Cells, Cultured | 2000 |
Resveratrol suppresses hepatoma cell invasion independently of its anti-proliferative action.
Topics: Animals; Antineoplastic Agents; Antioxidants; Carcinoma, Hepatocellular; Cell Division; Hypoxanthine; Liver Neoplasms; Neoplasm Invasiveness; Rats; Resveratrol; Stilbenes; Tumor Cells, Cultured; Xanthine Oxidase | 2001 |
Trans-resveratrol, a grapevine-derived polyphenol, blocks hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Division; Cell Survival; Flavonoids; Hepatocyte Growth Factor; Humans; Liver Neoplasms; Mitogen-Activated Protein Kinase Kinases; Neoplasm Invasiveness; Phenols; Phosphorylation; Poly(ADP-ribose) Polymerases; Polymers; Polyphenols; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Resveratrol; RNA, Messenger; Stilbenes; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 2001 |